Impact of Dapagliflozin for the Regulation of Immunological Activity in Membranous Nephropathy
Clinical trial NCT07096986 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07096986
- Sponsor
- Centre Hospitalier Universitaire de Nice
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-11-01
- Primary completion
- 2027-11-01
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.